Search Results for "Invokamet"
Search again or select article below to purchase. Single article price: $45. Order 3 or more at one time and receive a 10% discount.
Sort by relevance | Sort by date
Searched for Invokamet. Results 1 to 3 of 3 total matches.
See also: canagliflozin, metformin
In Brief: Canagliflozin and Lower Limb Amputations
The Medical Letter on Drugs and Therapeutics • Sep 21, 2020 (Issue 1607)
, Invokamet,
Invokamet XR) that described an increased risk of lower
limb amputation associated with use ...
The FDA has removed a boxed warning from the labeling
of products containing the sodium-glucose co-transporter
2 (SGLT2) inhibitor canagliflozin (Invokana, Invokamet,
Invokamet XR) that described an increased risk of lower
limb amputation associated with use of the drug. Package
inserts for canagliflozin products still contain a standard
warning about a risk of lower limb amputation.
Comparison Chart: SGLT2 Inhibitors (online only)
The Medical Letter on Drugs and Therapeutics • Nov 16, 2020 (Issue 1611)
; HFrEF = heart failure with reduced ejection fraction Invokana Invokamet Glyxambi Forxiga Farxiga ...
View the Comparison Chart: SGLT2 Inhibitors
Drugs for Type 2 Diabetes
The Medical Letter on Drugs and Therapeutics • Nov 14, 2022 (Issue 1663)
– Invokamet 500/50, 1000/50, 500/150, 500/50-500/150 mg PO bid4,39 570.10
(Janssen) 1000/150 mg tabs ...
Diet, exercise, and weight loss can improve glycemic
control, but almost all patients with type 2 diabetes
require antihyperglycemic drug therapy. Treating to
a target A1C of <7% while minimizing hypoglycemia
is recommended to prevent microvascular complications
of diabetes (retinopathy, nephropathy, and
neuropathy). An A1C target of <8% may be appropriate
for some older patients.